Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-13

Clinical Trial Update: Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder [NA]

View source ↗

Summary

A clinical trial evaluating medication management for Attention-deficit/hyperactivity disorder has been withdrawn. The study identified as NCT01769300 is no lon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: American Academy of Pediatrics | Conditions: Attention Deficit-hyperactivity Disorder | NA | Status: WITHDRAWN